|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.52 USD | -0.13% |
|
-0.25% | +79.42% |
| Market Cap | 8.81B 7.66B 7.13B 6.54B 12.35B 841B 12.55B 83.99B 32.96B 419B 33.07B 32.35B 1,403B | P/E 2026 * |
-17.7x | P/E 2027 * | -20x |
|---|---|---|---|---|---|
| Enterprise Value | 7.77B 6.76B 6.29B 5.77B 10.9B 742B 11.07B 74.12B 29.09B 369B 29.19B 28.54B 1,238B | EV / Sales 2026 * |
113x | EV / Sales 2027 * | 46.1x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | -0.13% | ||
| 1 week | -0.25% | ||
| 1 month | +97.77% | ||
| 3 months | +114.04% | ||
| 6 months | +69.24% | ||
| Current year | +79.42% |
| 1 week | 83.47 |  | 83.98 |
| 1 month | 41.39 | | 84 |
| Current year | 32.3 | | 84 |
| 1 year | 25.83 | | 84 |
| 3 years | 15.76 | | 84 |
| 5 years | 15.23 | | 84 |
| 10 years | 10.63 | | 84 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% | ||
| 2/23/26 | Free | Chief Financial Officer | 82,000 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -0.25% | +200.00% | +335.68% | 8.81B | |
| +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +63.59% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| -0.41% | -0.16% | +23.64% | -14.88% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -30.63% | 17.56B | |
| -2.85% | -8.43% | +16.33% | +545.44% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.75% | -3.44% | +51.98% | +176.09% | 24.27B | |
| Weighted average by Cap. | -0.23% | -2.86% | +36.75% | +127.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 68.49M 59.54M 55.42M 50.88M 96.09M 6.54B 97.57M 653M 256M 3.26B 257M 252M 10.91B | 172M 150M 139M 128M 242M 16.44B 245M 1.64B 645M 8.18B 647M 632M 27.44B |
| Net income | -516M -449M -418M -384M -725M -49.3B -736M -4.93B -1.93B -24.55B -1.94B -1.9B -82.31B | -473M -411M -382M -351M -663M -45.11B -673M -4.51B -1.77B -22.46B -1.77B -1.74B -75.31B |
| Net Debt | -1.04B -900M -837M -769M -1.45B -98.81B -1.47B -9.87B -3.87B -49.19B -3.89B -3.8B -165B | -865M -752M -700M -643M -1.21B -82.59B -1.23B -8.25B -3.24B -41.12B -3.25B -3.18B -138B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$83.52 | -0.13% | 1,863,939 |
| 26-07-30 | US$83.63 | -0.30% | 2,109,649 |
| 26-07-29 | US$83.88 | +0.02% | 1,621,555 |
| 26-07-28 | US$83.86 | +0.01% | 2,316,639 |
| 26-07-27 | US$83.85 | +0.14% | 5,216,887 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
